Cargando…
miR-142-3p regulates autophagy by targeting ATG16L1 in thymic-derived regulatory T cell (tTreg)
Thymic-derived regulatory T cell (tTreg) clinical trials show therapeutic promise in the prevention of acute graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation patients. However, strategies are needed to improve tTreg proliferative ability and survival as a means...
Autores principales: | Lu, Yunjie, Gao, Ji, Zhang, Shaopeng, Gu, Jian, Lu, Hao, Xia, Yongxiang, Zhu, Qin, Qian, Xiaofeng, Zhang, Feng, Zhang, Chuanyong, shen, Hongbing, Hippen, Keli L., Blazar, Bruce R., Lu, Ling, Wang, Xuehao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833855/ https://www.ncbi.nlm.nih.gov/pubmed/29459719 http://dx.doi.org/10.1038/s41419-018-0298-2 |
Ejemplares similares
-
Capacity of tTreg generation is not impaired in the atrophied thymus
por: Oh, Jiyoung, et al.
Publicado: (2017) -
Foxp3 Instability Helps tTregs Distinguish Self and Non-self
por: Zhang, Zhongmei, et al.
Publicado: (2019) -
Rapamycin Regulates iTreg Function through CD39 and Runx1 Pathways
por: Lu, Yunjie, et al.
Publicado: (2014) -
PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib
por: Zhang, Kai, et al.
Publicado: (2018) -
Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration
por: Brinkman, C. Colin, et al.
Publicado: (2016)